Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2003
04/09/2003EP1299538A2 Secreted proteins
04/09/2003EP1299534A2 Grf2-binding proteins and applications thereof
04/09/2003EP1299412A2 Protein modification and maintenance molecules
04/09/2003EP1299411A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
04/09/2003EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
04/09/2003EP1299393A2 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299384A1 Indole derivatives useful for the treatment of cns disorders
04/09/2003EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
04/09/2003EP1299380A1 Indole derivatives useful for the treatment of cns disorders
04/09/2003EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003EP1299365A1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
04/09/2003EP1299362A1 Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof
04/09/2003EP1299357A1 Novel compounds
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1299157A1 Composition and applicator for topical substance delivery
04/09/2003EP1299126A2 Glutamic acid decarboxylase (gad) delivery system for treating neurodegenerative diseases
04/09/2003EP1299125A1 Production, stabilisation and use of reduced forms of pharmaceutical compounds
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1299122A2 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
04/09/2003EP1299107A2 Highly concentrated stable meloxicam solutions
04/09/2003EP1299104A1 Tamper-resistant oral opioid agonist formulations
04/09/2003EP1299103A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
04/09/2003EP1299102A2 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy
04/09/2003EP1299099A2 Novel use of (r)-(-)-2- 5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts
04/09/2003EP1299011A2 Composition for the treatment of migraine
04/09/2003EP1299010A1 Vitamin k and essential fatty acids
04/09/2003EP1298994A2 Method for opening the blood-brain barrier
04/09/2003EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1198453B1 N-(indolcarbonyl-)piperazin derivatives
04/09/2003EP1149101B1 4-OXO-3,5-DIHYDRO-4$i(H)-PYRIDAZINO 4,5-$i(b)]INDOLE-1-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE
04/09/2003EP1091950B1 Substituted benzopyran derivatives and their use as anticonvulsants
04/09/2003EP1082116B1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
04/09/2003EP1049479A4 Analgesic from snake venom
04/09/2003EP1034255A4 Lineage restricted glial precursors from the central nervous system
04/09/2003EP0998494B1 Pompilid wasp-derived neuropeptides
04/09/2003EP0996612B1 Aliphatic propargylamines as cellular rescue agents
04/09/2003EP0993458B1 3-benzylpiperidine
04/09/2003EP0993301B1 Cocaine receptor binding ligands
04/09/2003EP0956013B1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
04/09/2003EP0915875B1 Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
04/09/2003EP0906303B1 Ring-fused dihydropyranes, process for the preparation and use thereof
04/09/2003EP0904273B1 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
04/09/2003EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/09/2003EP0902684B1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
04/09/2003EP0892793B1 Substituted tetracyclic tetrahydrofuran derivatives
04/09/2003EP0874641B1 Igf-i and -ii for the treatment of diseases of the central nervous system
04/09/2003EP0771197B1 Use of heterocyclic compounds as dopamines-d 3- ligands
04/09/2003EP0724439B1 Use of 2-(2alkylphenylamino)oxazolines and -thiazolines for the manufacture of a medicament with alpha 2 adrenergic effect
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003CN1409726A Type I cytokine receptor TCCR
04/09/2003CN1409722A Antagonists of BMP and TGF beta signalling pathway
04/09/2003CN1409716A New amino propylphosphinic acid
04/09/2003CN1409715A Cyclopenteneone derivatives
04/09/2003CN1409712A Pyrrolo [2,3-d] pyrimidine compounds
04/09/2003CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder
04/09/2003CN1409633A Combinations of(S)-2-(benzylamino-methyl)-2,3,8,9-tetrahydro-7H-1,4-dioxion[2,3-e]indol-8-one and neuroleptics
04/09/2003CN1409632A Use of retigabin for treating neuropathic pain
04/09/2003CN1409630A Sustainable-release formulations for treating CNS-mediated disorders
04/09/2003CN1409587A Method for forming holes, using flexible connection board formed thereof and its producing method
04/09/2003CN1408726A Preparation of non-mitogenic recombination acid fibrolast growth factor (aFGF) mutant
04/09/2003CN1408714A Novel oripavine derivative and its medical use
04/09/2003CN1408442A Adsorbent for whole blood perfusion adsorbing therapy
04/09/2003CN1408427A Reduced type glutathione lozenge
04/09/2003CN1408424A Chinese herbal medicine recipe for curing psychosis
04/09/2003CN1408415A Sichuan Chinaberry ointment and its preparing method
04/09/2003CN1408413A Pellet capable of curing infantile anorexia and convulsion
04/09/2003CN1408397A Composition containing melatonin and galangal fruit traditional Chinese medicine
04/09/2003CN1408396A Jinyukang-oral medicine for curing depression
04/09/2003CN1408360A Use of algin oligosaccharide in anti-senility and anti-dementia
04/09/2003CN1105115C 1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]- spiro [isobenzofuran-1(3H),4'-piperidine)] hydrohalogenides
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105111C Pyrazine compounds
04/09/2003CN1105102C Amino-butenate compound and preparation method thereof
04/09/2003CN1105101C Beta-sultonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
04/09/2003CN1104910C Production of analgesic synergy by co-administration of sub-analtesic doses of mu-opioid. agonist and kappa-2 opoiid agonist
04/09/2003CN1104904C Natural tea for taking off the offect of drink and process for production thereof
04/09/2003CN1104901C Medicinal preparation containing lipophilicity inert gas
04/09/2003CN1104900C Use of 8,9-dehydroestrone as anti-oxidant
04/09/2003CN1104896C RAR-gamma antagonist ligand or RAR-alpha agonist ligand as apoptosis inhibitor
04/09/2003CN1104894C Pharmaceutical compositions containing hydroximic acid derivatives
04/09/2003CN1104891C Controlled release preparation
04/08/2003WO2004028529A1 Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
04/08/2003WO2002034715A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
04/08/2003US6545182 Methods and compositions for modulating alpha adrenergic receptor activity
04/08/2003US6545149 Synthesis and crystallization of piperazine ring-containing compounds
04/08/2003US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins
04/08/2003US6545127 Catalytically active recombinant memapsin and methods of use thereof
04/08/2003US6545057 Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
04/08/2003US6545050 Aryl sulphonamide amino acid esters and analogues
04/08/2003US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof
04/08/2003US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example
04/08/2003US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group
04/08/2003US6545030 1-heterocycle substituted diarylamines
1 ... 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 ... 1833